<!-- received="Tue Sep  8 20:53:20 1998 MDT" -->
<!-- sent="Tue, 8 Sep 1998 19:53:14 -0700 (PDT)" -->
<!-- name="Doug Skrecky" -->
<!-- email="oberon@vcn.bc.ca" -->
<!-- subject="aminoguanidine and diabetic mice" -->
<!-- id="Pine.GSO.3.95.980908195244.5329C-100000@opus.vcn.bc.ca" -->
<!-- inreplyto="" -->
<!-- version=1.10, linesinbody=27 -->
<html><head><title>extropians: aminoguanidine and diabetic mice</title>
<meta name=author content="Doug Skrecky">
<link rel=author rev=made href="mailto:oberon@vcn.bc.ca" title ="Doug Skrecky">
</head><body>
<h1>aminoguanidine and diabetic mice</h1>
Doug Skrecky (<i>oberon@vcn.bc.ca</i>)<br>
<i>Tue, 8 Sep 1998 19:53:14 -0700 (PDT)</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#2242">[ date ]</a><a href="index.html#2242">[ thread ]</a><a href="subject.html#2242">[ subject ]</a><a href="author.html#2242">[ author ]</a>
<!-- next="start" -->
<li><a href="2243.html">[ Next ]</a><a href="2241.html">[ Previous ]</a>
<!-- nextthread="start" -->
</ul>
<!-- body="start" -->

<p>
Authors
<br>
  Friedman EA.  Distant DA.  Fleishhacker JF.  Boyd TA.  Cartwright K.
Institution
<br>
  Department of Medicine, State University of New York, Health Science Center
  at Brooklyn, 11203-2098, USA. elifreidmn:aol.com
Title
<br>
  Aminoguanidine prolongs survival in azotemic-induced diabetic rats.
Source
<br>
  American Journal of Kidney Diseases.  30(2):253-9, 1997 Aug.
Abstract
<br>
  Toxic effects of hyperglycemia-induced advanced glycosylated
  end products (AGEs) may explain some vasculopathic
  complications of diabetes. Aminoguanidine, a known inhibitor of AGE
  formation, was administered by gavage to Sprague-Dawley
  streptozotocin-induced diabetic rats made azotemic by surgical reduction of
  renal mass. All rats became hyperglycemic. Renal ablation caused renal
  insufficiency, as evidenced by markedly reduced endogenous
  creatinine clearances at days 7 and 14. Aminoguanidine-treated rats had
  significantly (P &lt; 0.04) superior survival to that of untreated azotemic
  diabetic rats. We infer from the extended life in a rat
  model of uremia in diabetic nephropathy that aminoguanidine may prove
  beneficial in human diabetes.
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="2243.html">[ Next ]</a><a href="2241.html">[ Previous ]</a>
<!-- nextthread="start" -->
</ul>
</body></html>
